YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
11.40
-0.40 (-3.39%)
Jan 15, 2026, 2:55 PM EST - Market open
YD Bio Market Cap
YD Bio has a market cap or net worth of $801.65 million as of January 15, 2026. Its market cap has increased by 1,486.90% in one year.
Market Cap
801.65M
Enterprise Value
812.60M
1-Year Change
1,486.90%
Ranking
Category
Stock Price
$11.40
Market Cap Chart
Since December 23, 2020, YD Bio's market cap has increased from $148.36M to $801.65M, an increase of 440.35%. That is a compound annual growth rate of 39.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 829.77M | -3.20% |
| Dec 31, 2025 | 857.20M | 1,788.97% |
| Dec 26, 2024 | 45.38M | -4.31% |
| Dec 28, 2023 | 47.42M | -5.87% |
| Dec 30, 2022 | 50.38M | -66.30% |
| Dec 31, 2021 | 149.47M | 3.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.85B |
| Johnson & Johnson | 502.24B |
| AbbVie | 387.32B |
| UnitedHealth Group | 307.46B |
| AstraZeneca | 295.57B |
| Novartis AG | 272.98B |
| Merck & Co. | 271.71B |
| Novo Nordisk | 263.81B |